AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31070845
Drug: Desoximetasone ointment
RxNorm normalized name: Desoximetasone Ointment
DrugBank: Desoximetasone (DB00547)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desoximetasone ointment
Trial: 3367488
Drug: Cendehill rubella
RxNorm normalized name: rubella virus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cendehill rubella virus vaccine
Trial: 29856344
Drug: Combined vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined vaccine groups
Trial: 3677542
Drug: Lamotrigine 240
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine 240 mg
Trial: 6757152
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg mepindolol plus 12.5 mg hydrochlorothiazide daily
Trial: 22175055
Drug: 2 L
RxNorm normalized name: H-2 locus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 L PEG + 20 mg bisacodyl
Trial: 31672177
Drug: Ticagrelor monotherapy
RxNorm normalized name: Ticagrelor
DrugBank: Ticagrelor (DB08816)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ticagrelor monotherapy after 1-month DAPT
Trial: 19483232
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of tranexamic acid
Trial: 7402771
Drug: Oral salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral salbutamol
Trial: 20528839
Drug: Interpleural analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpleural analgesia with a 20-ml loading dose of levo bupivacaine 0.5% followed by a continuous infusion of levobupivacaine 0.125%
Trial: 20528839
Drug: Multimodal analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal analgesia with intravenous morphine patient‐controlled analgesia
Trial: 23933905
Drug: Metadoxine extended
RxNorm normalized name: metadoxine
DrugBank: Metadoxine (DB16554)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metadoxine extended release (ER) 1400 mg/day for 6 weeks
Trial: 7880667
Drug: Ketorolac 10
RxNorm normalized name: ketorolac 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac 10 mg i.v.
Trial: 12590005
Drug: Calcium plus
RxNorm normalized name: O Calcium Plus D
DrugBank: Cupric oxide (DB11134)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium plus Kava-Kava 100 mg/day
Trial: 2866492
Drug: Terazosin 10
RxNorm normalized name: terazosin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin 10 mg once daily
Trial: 20530322
Drug: Rituximab administered
RxNorm normalized name: Rituximab
DrugBank: Rituximab (DB00073)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Rituximab administered at 375 mg/m² weekly for 4 doses
Trial: 15545669
Drug: Concurrent radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Concurrent radiotherapy (CONC RT)
Trial: 2650879
Drug: Naproxen 750
RxNorm normalized name: naproxen 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 750 mg at the first symptom of the attack, total allowed 1250 mg per 24 h
Trial: 30732618
Drug: Liberal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liberal treatment protocol (3 μg/kg)
Trial: 1741738
Drug: Cognitive-behaviour therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behaviour therapy (individual or group)
Trial: 6807240
Drug: Prostacycline (PGI2)
RxNorm normalized name: PGI2
DrugBank: Epoprostenol (DB01240)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prostacycline (PGI2) infusion at 25 ng/Kg/min before Heparin, then 50 ng/Kg/min during bypass
Trial: 27657546
Drug: Methylene Blue
RxNorm normalized name: Methylene Blue
DrugBank: Methylene blue (DB09241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylene Blue Injection
Trial: 15654576
Drug: iomeprol 400
RxNorm normalized name: Iomeprol 400 MG/1 ML Injection Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iomeprol 400 mg iodine/mL
Trial: 31631570
Drug: Palliative intent
RxNorm normalized name: Various pain palliation radiopharmaceuticals
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Palliative intent treatment
Trial: 26166526
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (only accepted oral examination for 3 years)
Trial: 15498362
Drug: Intracoronary injection
RxNorm normalized name: HELIUM 992 mL in 1 L INTRACORONARY GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary injection of BMSCs
Trial: 10442206
Drug: Sustained release
RxNorm normalized name: Sustained Release Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained release tablet (reference substance)
Trial: 23035175
Drug: ACE527 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE527 vaccine (10^11 CFU, two doses 21 days apart)
Trial: 18031520
Drug: Dronedarone 400
RxNorm normalized name: dronedarone 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronedarone 400 mg bid
Trial: 17514629
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (P)
Trial: 2090770
Drug: recombinant interferon
RxNorm normalized name: Recombinant Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant interferon alpha‐2b (rIFN alpha‐2b) 5 MU/m2 thrice weekly for 16 weeks
Trial: 28459181
Drug: Advanced Moist
RxNorm normalized name: Sunmark Advanced Moisturizer Eye Drops
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advanced Moist Wound Therapy (Control)
Trial: 26683057
Drug: Low-dose-induction oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose-induction oral immunotherapy (OIT) with 3 ml of milk, administered daily after a 5-day hospital build-up period.
Trial: 22672584
Drug: Immediately placed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediately placed implants in sockets with periapical pathology
Trial: 22672584
Drug: Immediately placed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediately placed implants in sockets without periapical pathology (control group)
Trial: 16984757
Drug: Artificial cycles
RxNorm normalized name: COLOR,ARTIFICIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial cycles with oral oestradiol and vaginal oestradiol if needed
Trial: 31838256
Drug: Genetically-guided therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genetically-guided therapy (Group G)
Trial: 23652909
Drug: Isotretinoin therapy
RxNorm normalized name: Isotretinoin
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isotretinoin therapy
Trial: 26531051
Drug: Topical voriconazole
RxNorm normalized name: Voriconazole
DrugBank: Voriconazole (DB00582)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical voriconazole
Trial: 14567768
Drug: Transdermal 17beta-estradiol
RxNorm normalized name: Estradiol-17beta
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal 17beta-estradiol plus intermittent medroxyprogesterone acetate (MPA)
Trial: 15831776
Drug: N-desmethyl adinazolam
RxNorm normalized name: N-ethylurea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-desmethyl adinazolam (NDMAD, 10 mg)
Trial: 19840302
Drug: New baby
RxNorm normalized name: Little Remedies New Baby Essentials Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New baby wipe formulation
Trial: 12579547
Drug: Self-administered behavioral
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered behavioral treatment with written manuals
Trial: 3412049
Drug: Binedaline with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Binedaline with alcohol (0.8 g/kg)
Trial: 30777570
Drug: Methylprednisolone injection
RxNorm normalized name: methylprednisolone Injection
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone injection (1 g in two 500 mg doses)
Trial: 19486346
Drug: CNI treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CNI treatment
Trial: 8312826
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with zidovudine (AZT) alone
Trial: 8312826
Drug: Monotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monotherapy with zidovudine (AZT)
Trial: 3789208
Drug: transitional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: transitional treatment
Trial: 21722003
Drug: control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: control treatment
Trial: 26762247
Drug: Intraoral PBM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoral PBM treatment
Trial: 23084379
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of venular width and arteriolar tortuosity
Trial: 19202152
Drug: Oseltamivir (antiviral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oseltamivir (antiviral agent)
Trial: 17688919
Drug: Discontinuing low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Discontinuing low-dose aspirin (LDA)
Trial: 17688919
Drug: Continuing low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Continuing low-dose aspirin (LDA)
Trial: 17688919
Drug: Replacing LDA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Replacing LDA with low-molecular-weight heparin
Trial: 15184213
Drug: Ibuprofen (4-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (4-10 mg/kg)
Trial: 15184213
Drug: Ibuprofen (5-10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (5-10 mg/kg)
Trial: 15184213
Drug: Ibuprofen and
RxNorm normalized name: Ibuprofen and Famotidine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen and acetaminophen
Trial: 9482142
Drug: 240 mg
RxNorm normalized name: aspirin 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 240 mg sustained release verapamil
Trial: 27802233
Drug: Multimodal Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal Cognitive Enhancement Therapy (MCET)
Trial: 19858812
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (internal medicine residents only)
Trial: 17826451
Drug: Pain-centered treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pain-centered treatment (PCT)
Trial: 30464426
Drug: Passive finger
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Passive finger exercises (25 minutes daily for 12 weeks)
Trial: 20196970
Drug: 225 g
RxNorm normalized name: Sutab, 0.225 g-0.188 g-1.479 g oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 225 g of cold water prawns
Trial: 7751527
Drug: Intranasal ipratropium
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal ipratropium bromide (0.03%, 0.06%, and 0.12% dosage strengths); 2 sprays per nostril (total dose of 84, 168, and 336 micrograms)
Trial: 7751527
Drug: Intranasal ipratropium
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal ipratropium bromide (0.03% and 0.06% dosage strengths) in patients with perennial rhinitis
Trial: 7751527
Drug: Intranasal ipratropium
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intranasal ipratropium bromide (0.06% dosage strength) in patients with the common cold
Trial: 31621252
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Electroacupuncture + PNF)
Trial: 25703961
Drug: Riociguat up
RxNorm normalized name: Riociguat
DrugBank: Riociguat (DB08931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Riociguat up to 1.5 mg 3 times daily
Trial: 23174368
Drug: Extended release
RxNorm normalized name: Tylenol Extended Release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended release (ER) niacin (1500 mg per day)
Trial: 9071101
Drug: Propofol (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (2.5 mg.kg‐1) with fentanyl (0.2 microgram.kg‐1)
Trial: 9071101
Drug: Midazolam (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.2 mg.kg‐1) with fentanyl (0.2 microgram.kg‐1)
Trial: 9071101
Drug: Thiopental (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental (5 mg.kg‐1) with fentanyl (0.2 microgram.kg‐1)
Trial: 15522941
Drug: Oral medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral medroxyprogesterone acetate (MPA)
Trial: 2939943
Drug: Oral medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral medroxyprogesterone acetate (MPA) after cross-over
Trial: 31391104
Drug: Electroacupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture plus warm needling therapy (treatment group)
Trial: 22382203
Drug: Cranberry juice
RxNorm normalized name: cranberry juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranberry juice (CJ) - double-strength Ocean Spray light CJ (2 × 230 ml) daily for 4 months
Trial: 12709008
Drug: Skin whitening
RxNorm normalized name: ASCORBYL GLUCOSIDE 1.5 g in 1 mg BUCCAL EMULSION [skin whitening]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skin whitening complex 5% cream
Trial: 10906303
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment of small AAAs
Trial: 10906303
Drug: Surgery after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgery after conservative treatment
Trial: 12150618
Drug: Topical budesonide
RxNorm normalized name: budesonide Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical budesonide
Trial: 29653635
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg daily aspirin
Trial: 24565347
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (50 μg and 100 μg)
Trial: 16751657
Drug: Vitamin K1
RxNorm normalized name: vitamin K1
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K1 10 mg per day for 2-7 days (Group A)
Trial: 16751657
Drug: Dexamethasone 10
RxNorm normalized name: dexamethasone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 10 mg per day for 1 day and Vitamin K1 10 mg per day for 2-7 days (Group D)
Trial: 15632893
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg/day (aggressive lipid lowering)
Trial: 16356804
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg/day (moderate lipid lowering)
Trial: 15374306
Drug: Pramiracetam (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramiracetam (600 mg twice a day)
Trial: 25177815
Drug: Meldonium administered
RxNorm normalized name: meldonium
DrugBank: Meldonium (DB13723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Meldonium administered at a dose of 1000 mg/ml intravenously in addition to controlled physical training (CPT) with intensity 80% for 2 weeks (10 SFI)
Trial: 22920930
Drug: Prasugrel (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (5 mg daily)
Trial: 9892520
Drug: Clopidogrel (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (75 mg daily)
Trial: 23602770
Drug: Prasugrel (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (10 mg daily)
Trial: 18754820
Drug: 1.5 mcg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mcg/kg fentanyl
Trial: 16129547
Drug: Oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin infusion (starting from 2 mIU/min, increasing every 30 min with 2 mIU/min increments up to 40 mIU/min)
Trial: 31498862
Drug: Papaverine injection
RxNorm normalized name: papaverine Injection
DrugBank: Papaverine (DB01113)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Papaverine injection
Trial: 30565407
Drug: BioChaperone insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: BioChaperone insulin Lispro (BCLIS)
Trial: 29770541
Drug: sitagliptin 50
RxNorm normalized name: SITagliptin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sitagliptin 50 mg qd
Trial: 27015624
Drug: Tramadol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (1 mg/kg with 100 mL normal saline)
Trial: 27015624
Drug: Paracetamol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (1 g intravenously)
Trial: 27015624
Drug: Dexketoprofen (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen (50 mg intravenously)
Trial: 8965976
Drug: Carbamazepine (CBZ)
RxNorm normalized name: Carbamazepine
DrugBank: Carbamazepine (DB00564)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carbamazepine (CBZ) 2 x 200 mg daily
Trial: 2998219
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose fentanyl anaesthesia (0.01 mg/kg bw) - Group A
Trial: 24880194
Drug: Suprascapular nerve
RxNorm normalized name: nerve growth factor
DrugBank: Nerve Growth Factor (DB12620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suprascapular nerve block (SSNB) with 10 mL 0.75% ropivacaine and axillary nerve block (ANB) with 10 mL saline
Trial: 22301207
Drug: IV lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IV lidocaine (0.5, 1.0, or 1.5 mg/kg) with placebo
Trial: 12466788
Drug: High-dose dipyridamole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dipyridamole infusion (0.70 mg/kg) followed by technetium 99m tetrofosmin (TF) injection (74 to 370 MBq)
Trial: 7855555
Drug: Cefpodoxime proxetil
RxNorm normalized name: Cefpodoxime Proxetil
DrugBank: Cefpodoxime (DB01416)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefpodoxime proxetil (CP) 8 mg/kg/d b.i.d.
Trial: 7855555
Drug: Amoxicillin/clavulanic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanic acid (ACA) 40/10 mg/kg/d t.i.d.
Trial: 4908340
Drug: Aerosol administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aerosol administration of influenza vaccine
Trial: 4908340
Drug: Subcutaneous administration
RxNorm normalized name: subcutaneous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous administration of A2/Hong Kong/68 virus vaccine
Trial: 4908340
Drug: Bivalent (A2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bivalent (A2 and B) influenza virus vaccine
Trial: 4908340
Drug: Single-dose immunization
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose immunization
Trial: 4908340
Drug: 2-dose immunization
RxNorm normalized name: immunoglobulin G
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-dose immunization
Trial: 27981743
Drug: Whey protein
RxNorm normalized name: Whey protein
DrugBank: Whey (DB18685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whey protein isolate (WPI) 50 g
Trial: 27981743
Drug: Soy protein
RxNorm normalized name: Soy Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soy protein isolate (SPI) 50 g
Trial: 25311146
Drug: Dexmedetomidine 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine 0.3 μg.kg(‐1)
Trial: 18095967
Drug: Propofol 1
RxNorm normalized name: propofol 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 1 mg.kg(‐1)
Trial: 21444712
Drug: FV-100 200
RxNorm normalized name: HORSERADISH 10 g in 100 mL TOPICAL LIQUID [NWK A-FV]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FV-100 200 mg QD for 7 days
Trial: 21444712
Drug: FV-100 800
RxNorm normalized name: HORSERADISH 10 g in 100 mL TOPICAL LIQUID [NWK A-FV]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FV-100 800 mg QD for 7 days
Trial: 21444712
Drug: Single 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 400 mg dose of FV-100
Trial: 21444712
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg QD dosing regimen for 7 days in elderly subjects
Trial: 21444712
Drug: FV-100 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FV-100 (all doses)
Trial: 18192843
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg nicotine tabs
Trial: 16455186
Drug: Diclofenac 50
RxNorm normalized name: DICLOFENAC 50MG/MISOPROSTOL 200MCG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac 50 mg enteric‐coated tablet